`
`__________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`__________
`
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owners
`
`__________
`
`
`Case IPR2021-00816
`Patent No. 9,220,631
`
`__________
`
`
`PATENT OWNERS’ NOTICE OF DEPOSITION OF
`SZILÁRD KISS UNDER C.F.R. § 42.53
`
`
`
`
`
`
`
`
`
`
`
`IPR2021-00816
`Patent Owners’ Notice of Deposition of Szilárd Kiss
`
`
`
`
`
`Please take notice that pursuant to 37 C.F.R. § 42.53, Patent Owners will
`
`take the deposition of Szilárd Kiss, upon oral examination. The deposition will be
`
`taken on January 7, 2022 beginning at 9:00 a.m. EST, via remote videoconference.
`
`The deposition will be videotaped and recorded by stenographic means by a court
`
`reporter licensed to administer oaths. In accordance with 37 C.F.R. § 42.53(d)(1),
`
`the parties have conferred and agreed upon the date, time and location of the
`
`deposition.
`
`
`
`
`
`
`
`
`
`
`Dated: December 23, 2021
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Elizabeth J. Holland/
`Elizabeth J. Holland (Reg. No. 47,657)
`Lead Counsel for Patent Owners
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Phone: (212) 813-8800
`Fax: (212) 355-3333
`EHolland@goodwinlaw.com
`
`1
`
`
`
`IPR2021-00816
`Patent Owners’ Notice of Deposition of Szilárd Kiss
`
`
`
`
`CERTIFICATE OF SERVICE
`A copy of this Patent Owners’ Notice of Deposition of Szilárd Kiss under
`
`
`
`C.F.R. § 42.53 has been served on Petitioner’s attorneys of record as follows via
`
`electronic mail:
`
`Elizabeth Stotland Weiswasser
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8022
`F: 212-310-8007
`elizabeth.weiswasser@weil.com
`USPTO Reg. No. 55,721
`Anish R. Desai
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`anish.desai@weil.com
`USPTO Reg. No. 73,760
`
`Natalie Kennedy
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`natalie.kennedy@weil.com
`USPTO Reg. No. 68,511
`Andrew Gesior
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`
`
`
`2
`
`
`
`
`
`T: 212-310-8730
`F: 212-310-8007
`andrew.gesior@weil.com
`USPTO Reg. No. 76,588
`
`Brian E. Ferguson
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`brian.ferguson@weil.com
`USPTO Reg. No. 36,801
`
`Christopher M. Pepe
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`christopher.pepe@weil.com
`USPTO Reg. No. 73,851
`
`Regeneron.IPR.Service@weil.com
`Attorneys for Regeneron Pharmaceuticals, Inc.
`Dated: December 23, 2021
`
`/Elizabeth J. Holland/
`Elizabeth J. Holland (Reg. No. 47,657)
`Lead Counsel for Patent Owners
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Phone: (212) 813-8800
`Fax: (212) 355-3333
`EHolland@goodwinlaw.com
`
`
`
`
`
`3
`
`